Page last updated: 2024-09-04

gla 27 and HIV

gla 27 has been researched along with HIV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bozzacco, L; Brane, L; Cheong, C; Dandamudi, D; Longhi, MP; Mehandru, S; Pantel, A; Ruane, D; Shrestha, E; Steinman, RM; Teixeira, A	1

Other Studies

1 other study(ies) available for gla 27 and HIV

Article	Year
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo. European journal of immunology, 2012, Volume: 42, Issue:1 Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Dendritic Cells; HIV; HIV Core Protein p24; Lipid A; Lymphoid Tissue; Mice; Mice, Inbred C57BL; Mice, Knockout; Specific Pathogen-Free Organisms; Toll-Like Receptor 4; Vaccines, Subunit	2012

Article

Year

A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.

European journal of immunology, 2012, Volume: 42, Issue:1

Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Dendritic Cells; HIV; HIV Core Protein p24; Lipid A; Lymphoid Tissue; Mice; Mice, Inbred C57BL; Mice, Knockout; Specific Pathogen-Free Organisms; Toll-Like Receptor 4; Vaccines, Subunit

2012